SKG小鼠间质性肺病中CD11b+Gr-1dim耐受性树突状细胞样细胞扩增
本研究在SKG小鼠间质性肺病(ILD)模型中分析肺浸润细胞,发现严重炎症肺组织中CD11b+Gr-1dim耐受性树突状细胞样细胞扩增,该细胞可由单核细胞MDSC在GM-CSF诱导下产生并抑制T细胞增殖,过继转移可显著抑制ILD进展。
要点
- SKG小鼠ILD肺中MDSC、Th17、ILC1和ILC3增多,比例随ILD严重程度变化。
- 严重炎症肺中CD11b+Gr-1dim细胞扩增,约半数表达CD11c,具有抑制T细胞增殖的耐受性。
- 过继转移CD11b+Gr-1dim耐受性DC样细胞可显著抑制SKG小鼠ILD进展。
核心结论
- 在SKG小鼠ILD中鉴定出由单核细胞MDSC分化而来的CD11b+Gr-1dim耐受性DC样细胞,过继转移可抑制ILD进展。
研究设计与样本
- 采用组织学评估酵母多糖A诱导的SKG小鼠ILD严重程度,并通过流式细胞术分析肺浸润细胞。
主要发现
- ILD肺中MDSC、Th17细胞及ILC1、ILC3增多,其比例随ILD严重程度变化。
- 严重炎症肺中CD11b+Gr-1dim细胞扩增,约半数表达CD11c,并抑制T细胞增殖。
- CD11b+Gr-1dim细胞可在体外经GM-CSF从单核细胞MDSC诱导产生。
- 炎症肺中Th17、ILC1和ILC3产生GM-CSF,可能促进CD11b+Gr-1dim耐受性DC样细胞体内扩增。
- 过继转移CD11b+Gr-1dim耐受性DC样细胞显著抑制SKG小鼠ILD进展。
临床怎么用
- 提示CD11b+Gr-1dim耐受性DC样细胞可能作为ILD的潜在细胞治疗策略,但尚需人体研究验证。
局限性
- 研究仅基于SKG小鼠模型,结论能否外推至人类RA-ILD尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: SKG mice develop interstitial lung disease (ILD) resembling rheumatoid arthritis-associated ILD in humans. The aim of this study was to clarify the mechanism underlying the lung pathology by analyzing lung-infiltrating cells in SKG mice with ILD. METHODS: We assessed the severity of zymosan A (ZyA)-induced ILD in SKG mice histologically, and we examined lung-infiltrating cells by flow cytometry. Total lung cells and isolated monocytic myeloid-derived suppressor cells (MDSCs) were cultured in vitro with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4. The proliferation of 5,6-carboxyfluorescein diacetate N-succinimidyl ester-labeled naive T cells cocultured with isolated CD11b+Gr-1dim cells and MDSCs was evaluated by flow cytometry. CD11b+Gr-1dim cells were adoptively transferred to ZyA-treated SKG mice. RESULTS: MDSCs, Th17 cells, and group 1 and 3 innate lymphoid cells (ILC1s and ILC3s) were increased in the lungs; the proportion of these cells varied with ILD severity. In this process, we found that a unique cell population, CD11b+Gr-1dim cells, was expanded in the severely inflamed lungs. Approximately half of the CD11b+Gr-1dim cells expressed CD11c. CD11b+Gr-1dim cells were induced from monocytic MDSCs with GM-CSF in vitro and were considered tolerogenic because they suppressed T cell proliferation. These CD11b+Gr-1dim cells have never been described previously, and we termed them CD11b+Gr-1dim tolerogenic dendritic cell (DC)-like cells. Th17 cells, ILC1s, and ILC3s in the inflamed lung produced GM-CSF, which may have expanded CD11b+Gr-1dim tolerogenic DC-like cells in vivo. Furthermore, adoptive transfer of CD11b+Gr-1dim tolerogenic DC-like cells significantly suppressed progression of ILD in SKG mice. CONCLUSION: We identified unique suppressive myeloid cells that were differentiated from monocytic MDSCs in SKG mice with ILD, and we termed them CD11b+Gr-1dim tolerogenic DC-like cells.
引用
- Sendo S, Saegusa J, Okano T, et al. CD11b+Gr-1dim Tolerogenic Dendritic Cell-Like Cells Are Expanded in Interstitial Lung Disease in SKG Mice. Arthritis Rheumatol. 2017. PMID: 28805019. doi:10.1002/art.40231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。